Advanced Enzyme Technologies Ltd has announced a conference call to discuss its unaudited financial results for the quarter and nine months ended December 31, 2025. The call is scheduled for February 04, 2026, providing investors and analysts an opportunity to engage with the company's management regarding its Q3FY26 performance.

Conference Call Details

The company will host the conference call on Wednesday, February 04, 2026, at 4:00 PM IST. This announcement was made in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Management Participation

The conference call will feature key members of the company's leadership team who will present and discuss the financial results with participants.

Participation Guidelines

Participants are advised to dial the conference numbers at least 5-10 minutes prior to the scheduled time to ensure timely connection. The company has provided primary dial-in numbers +91 86 3416 8799 and +91 86 4536 6917 for domestic participants. International participants can use the participant PIN number 1972863# for access.

Contact Information

For investor relations queries and RSVP, participants can contact Ronak Saraf at ir@advancedenzymes.com or +91 86578 64146. The company has also made pre-registration available to avoid wait times during the call. All relevant information regarding the conference call has been uploaded on the company's official website as part of its disclosure requirements.

Advanced Enzyme Technologies Limited has notified stock exchanges regarding the structural conversion of its statutory auditing firm from M S K A & Associates to M S K A & Associates LLP, effective January 13, 2026. The company received formal intimation from the auditors on January 14, 2026, and subsequently informed BSE and NSE on January 15, 2026.

Auditor Firm Conversion Details

The statutory auditing firm M S K A & Associates, Chartered Accountants, has converted itself into a Limited Liability Partnership under the provisions of the Limited Liability Partnership Act, 2008. The firm is now operating as M S K A & Associates LLP, Chartered Accountants with a new ICAI Firm Registration Number 105047W/W101187.

Continuity of Audit Services

The conversion to LLP structure does not impact the ongoing audit engagement with Advanced Enzyme Technologies. The newly formed M S K A & Associates LLP will continue to function and discharge its duties as the statutory auditors of the company for the remaining period of their appointed term. This ensures seamless continuation of auditing services without any disruption to the company's statutory compliance requirements.

Regulatory Communication

Advanced Enzyme Technologies' Company Secretary and Head of Legal, Sanjay Basantani, communicated this development to both major stock exchanges where the company's shares are listed. The notification was sent to BSE Limited (Scrip Code: 540025) and National Stock Exchange of India Limited (Trading Symbol: ADVENZYMES) as part of regulatory disclosure requirements under applicable listing regulations.

The company emphasized that this structural change in the auditing firm is purely administrative and maintains the same professional relationship and audit standards that were previously established with M S K A & Associates.